Liver Disease

Developing a Model to Predict and Prevent Readmission in Patients With Cirrhosis

August 2nd 2021, 8:00pm


Patient-reported outcome measures may have a small impact on predicting which patients with cirrhosis will be readmitted to the hospital.

Review Examines Interaction Between 2 Distinct Liver Diseases

July 31st 2021, 12:50pm


One diagnosis challenge is that there is no specific biomarker, either for autoimmune hepatitis (AIH) or metabolic-associated fatty liver disease (MAFLD), either alone or if they exist concurrently.

Experts: Unified Global Approach Needed to Address NAFLD/NASH

July 29th 2021, 8:30pm


A new report is issuing a call to action to develop a global strategy to address the growing issue of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

Blood Test Could Identify Patients at Risk of Nonalcoholic Fatty Liver Disease, Study Says

July 23rd 2021, 11:15am


The gold standard for diagnosing liver disease is a liver biopsy, but researchers are seeking a simpler way to identify those at risk, given the silent nature of early disease and rising incidence around the globe.

Better Studies Needed on Nutritional Supplementation in NAFLD

July 21st 2021, 12:11pm


The current available studies on nutritional supplementation in nonalcoholic fatty liver disease (NALFD) highlight the need for more high-quality randomized controlled trials.

Survey Finds Physicians Lack Necessary Knowledge About NAFLD

July 16th 2021, 2:00pm


A survey of global physicians found a gap in knowledge of non-alcoholic fatty liver disease (NAFLD) despite the growing burden of the disease worldwide.

Review Discusses Growing Problem of Alcoholic Liver Disease

July 13th 2021, 3:00pm


The problem of alcoholic liver disease is growing in the United States, and obtaining treatment is difficult.

Caffeinated or Decaffeinated, Any Type of Coffee Appears to Protect the Liver

July 10th 2021, 9:30pm


Coffee contains hundreds of chemical compounds and comes in several forms, and according to a recent study, has a protective effect on the liver, no matter what the type.

NAFLD Increases Mortality in Children and Young Adults Over the Long Term

July 8th 2021, 8:30pm


A long-term Swedish study found that nonalcoholic fatty liver disease (NALFD) significantly increased mortality in children and young adults, particularly due to cancer, cardiometabolic disease, and liver disease.

Study Identifies MAGEA3 as Novel Therapeutic Target in Hepatocellular Carcinoma

July 1st 2021, 7:06pm


Manipulating the expression of MAGEA3 can help block the growth of hepatocellular carcinoma.